Skip to main content

The Trial to Reduce Antimicrobial Use in Nursing Home Residents With Alzheimer Disease and Other Dementias (TRAIN-AD): A Cluster Randomized Clinical Trial.

Publication ,  Journal Article
Mitchell, SL; D'Agata, EMC; Hanson, LC; Loizeau, AJ; Habtemariam, DA; Tsai, T; Anderson, RA; Shaffer, ML
Published in: JAMA internal medicine
September 2021

Antimicrobials are extensively prescribed to nursing home residents with advanced dementia, often without evidence of infection or consideration of the goals of care.To test the effectiveness of a multicomponent intervention to improve the management of suspected urinary tract infections (UTIs) and lower respiratory infections (LRIs) for nursing home residents with advanced dementia.A cluster randomized clinical trial of 28 Boston-area nursing homes (14 per arm) and 426 residents with advanced dementia (intervention arm, 199 residents; control arm, 227 residents) was conducted from August 1, 2017, to April 30, 2020.The intervention content integrated best practices from infectious diseases and palliative care for management of suspected UTIs and LRIs in residents with advanced dementia. Components targeting nursing home practitioners (physicians, physician assistants, nurse practitioners, and nurses) included an in-person seminar, an online course, management algorithms (posters, pocket cards), communication tips (pocket cards), and feedback reports on prescribing of antimicrobials. The residents' health care proxies received a booklet about infections in advanced dementia. Nursing homes in the control arm continued routine care.The primary outcome was antimicrobial treatment courses for suspected UTIs or LRIs per person-year. Outcomes were measured for as many as 12 months. Secondary outcomes were antimicrobial courses for suspected UTIs and LRIs when minimal criteria for treatment were absent per person-year and burdensome procedures used to manage these episodes (bladder catherization, chest radiography, venous blood sampling, or hospital transfer) per person-year.The intervention arm had 199 residents (mean [SD] age, 87.7 [8.0] years; 163 [81.9%] women; 36 [18.1%] men), of which 163 (81.9%) were White and 27 (13.6%) were Black. The control arm had 227 residents (mean [SD] age, 85.3 [8.6] years; 190 [83.7%] women; 37 [16.3%] men), of which 200 (88.1%) were White and 22 (9.7%) were Black. There was a 33% (nonsignificant) reduction in antimicrobial treatment courses for suspected UTIs or LRIs per person-year in the intervention vs control arm (adjusted marginal rate difference, -0.27 [95% CI, -0.71 to 0.17]). This reduction was primarily attributable to reduced antimicrobial use for LRIs. The following secondary outcomes did not differ significantly between arms: antimicrobials initiated when minimal criteria were absent, bladder catheterizations, venous blood sampling, and hospital transfers. Chest radiography use was significantly lower in the intervention arm (adjusted marginal rate difference, -0.56 [95% CI, -1.10 to -0.03]). In-person or online training was completed by 88% of the targeted nursing home practitioners.This cluster randomized clinical trial found that despite high adherence to the training, a multicomponent intervention promoting goal-directed care for suspected UTIs and LRIs did not significantly reduce antimicrobial use among nursing home residents with advanced dementia.ClinicalTrials.gov Identifier: NCT03244917.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

JAMA internal medicine

DOI

EISSN

2168-6114

ISSN

2168-6106

Publication Date

September 2021

Volume

181

Issue

9

Start / End Page

1174 / 1182

Related Subject Headings

  • Retrospective Studies
  • Respiratory Tract Infections
  • Patient Care Planning
  • Palliative Care
  • Nursing Homes
  • Male
  • Humans
  • Follow-Up Studies
  • Female
  • Dementia
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Mitchell, S. L., D’Agata, E. M. C., Hanson, L. C., Loizeau, A. J., Habtemariam, D. A., Tsai, T., … Shaffer, M. L. (2021). The Trial to Reduce Antimicrobial Use in Nursing Home Residents With Alzheimer Disease and Other Dementias (TRAIN-AD): A Cluster Randomized Clinical Trial. JAMA Internal Medicine, 181(9), 1174–1182. https://doi.org/10.1001/jamainternmed.2021.3098
Mitchell, Susan L., Erika M. C. D’Agata, Laura C. Hanson, Andrea J. Loizeau, Daniel A. Habtemariam, Timothy Tsai, Ruth A. Anderson, and Michele L. Shaffer. “The Trial to Reduce Antimicrobial Use in Nursing Home Residents With Alzheimer Disease and Other Dementias (TRAIN-AD): A Cluster Randomized Clinical Trial.JAMA Internal Medicine 181, no. 9 (September 2021): 1174–82. https://doi.org/10.1001/jamainternmed.2021.3098.
Mitchell SL, D’Agata EMC, Hanson LC, Loizeau AJ, Habtemariam DA, Tsai T, et al. The Trial to Reduce Antimicrobial Use in Nursing Home Residents With Alzheimer Disease and Other Dementias (TRAIN-AD): A Cluster Randomized Clinical Trial. JAMA internal medicine. 2021 Sep;181(9):1174–82.
Mitchell, Susan L., et al. “The Trial to Reduce Antimicrobial Use in Nursing Home Residents With Alzheimer Disease and Other Dementias (TRAIN-AD): A Cluster Randomized Clinical Trial.JAMA Internal Medicine, vol. 181, no. 9, Sept. 2021, pp. 1174–82. Epmc, doi:10.1001/jamainternmed.2021.3098.
Mitchell SL, D’Agata EMC, Hanson LC, Loizeau AJ, Habtemariam DA, Tsai T, Anderson RA, Shaffer ML. The Trial to Reduce Antimicrobial Use in Nursing Home Residents With Alzheimer Disease and Other Dementias (TRAIN-AD): A Cluster Randomized Clinical Trial. JAMA internal medicine. 2021 Sep;181(9):1174–1182.

Published In

JAMA internal medicine

DOI

EISSN

2168-6114

ISSN

2168-6106

Publication Date

September 2021

Volume

181

Issue

9

Start / End Page

1174 / 1182

Related Subject Headings

  • Retrospective Studies
  • Respiratory Tract Infections
  • Patient Care Planning
  • Palliative Care
  • Nursing Homes
  • Male
  • Humans
  • Follow-Up Studies
  • Female
  • Dementia